Drugs Made In America Acquisition II Corp. DMII
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3,877.27% | 4,867.14% | -- | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 830.43% | -13.04% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 1,777.59% | 2,932.76% | -- | -- | |
|
|
|||||
| Total Current Assets | 1,777.59% | 2,932.76% | -- | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 504,695.97% | 544,684.71% | -- | -- | |
| Total Assets | 453,251.15% | 484,890.87% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | |
| Total Accrued Expenses | 3,045.45% | 377.88% | -- | -- | |
| Short-term Debt | 51.36% | 79.93% | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 302.85% | 471.72% | -- | -- | |
| Total Other Current Liabilities | 302.85% | 471.72% | -- | -- | |
| Total Current Liabilities | 96.82% | 137.03% | -- | -- | |
|
|
|||||
| Total Current Liabilities | 96.82% | 137.03% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | 51.36% | 79.93% | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 162,350.96% | 187,569.83% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -96.00% | -96.00% | -- | -- | |
| Retained Earnings | -7,097.15% | -8,343.55% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -8,273.10% | -10,021.88% | -- | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -8,273.10% | -10,021.88% | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -8,273.10% | -10,021.88% | -- | -- | |
|
|
|||||